ENTRY       D10253            Mixture   Drug
NAME        Alogliptin benzoate and metformin hydrochloride;
            Kazano (TN);
            Vipdomet (TN)
PRODUCT     ALOGLIPTIN AND METFORMIN HYDROCHLORIDE (A-S Medication Solutions)
            KAZANO (Takeda Pharmaceuticals America)
  GENERIC   ALOGLIPTIN AND METFORMIN HYDROCHLORIDE (Padagis Israel Pharmaceuticals)
COMPONENT   Alogliptin benzoate [DR:D06553], Metformin hydrochloride [DR:D00944]
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG03032  Combination of metformin and DPP-4 inhibitor
REMARK      Therapeutic category: 3969
            ATC code: A10BD13
            Product: D10253<JP/US>
EFFICACY    Antidiabetic
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BD Combinations of oral blood glucose lowering drugs
                 A10BD13 Metformin and alogliptin
                  D10253  Alogliptin benzoate and metformin hydrochloride &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Combinations
               Alogliptin Benzoate/ Metformin Hydrochloride
                D10253  Alogliptin benzoate and metformin hydrochloride
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               396  Antidiabetic agents
                3969  Others
                 D10253  Alogliptin benzoate and metformin hydrochloride
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG03032  Combination of metformin and DPP-4 inhibitor
                D10253  Alogliptin benzoate and metformin hydrochloride
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               D10253  Alogliptin benzoate and metformin hydrochloride
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10253
DBLINKS     PubChem: 163312284
///
